07:00 , Jul 30, 2007 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Accugesics Inc. Boston, Mass. Technology: Substance P-opioid chimeric peptides for pain and subcutaneous biodegradable controlled-release localized delivery system Disease focus: Neurology Clinical status: Preclinical Founded: 2004 by Daniel Carr and Andrzej Lipkowski University collaborators: New England Medical College at Tufts University;...
07:00 , Jul 30, 2007 |  BioCentury  |  Emerging Company Profile

Accugesics: Beating tolerance

Opiates remain the primary treatment for moderate to severe pain, although the tendency to develop tolerance to the drugs and then dependence is a shortcoming for chronic use. Accugesics Inc. is developing chimeric peptides that...